Search

everythinglearnresearchcommunity

for

Search:↓

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Fire Needle Therapy may help bring back skin color in vitiligo by affecting cell growth signals.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Testosterone therapy increases bone density in older men with low testosterone levels.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Estrogen therapy can reduce skin aging but has cancer risks.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Treat scalp and beard fungal infections early with oral antifungal medication and sometimes topical therapy, avoiding unnecessary allergy tests and surgery.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Low-level laser therapy using near-infrared light may help heart conditions and promote healing by releasing nitric oxide.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Environmental cues can change the fate and function of epithelial cells, with potential for cell therapy.

Combination therapy promotes better hair growth and density.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.